273.1 is a legacy non-billable code used to specify a medical diagnosis of monoclonal paraproteinemia. This code was replaced on September 30, 2015 by its ICD-10 equivalent. References found for the code 273.1 in the Index of Diseases and Injuries:
273.1 is a legacy non-billable code used to specify a medical diagnosis of monoclonal paraproteinemia.
D47.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM D47.2 became effective on October 1, 2020. This is the American ICD-10-CM version of D47.2 - other international versions of ICD-10 D47.2 may differ. All neoplasms are classified in this chapter, whether ...
Paraproteinemia D89.2ICD-10-CM Diagnosis Code D89.2Hypergammaglobulinemia, unspecified2016 2017 2018 2019 2020 2021 Billable/Specific Code. benign D89.2 (familial) ICD-10-CM Diagnosis Code D89.2. Hypergammaglobulinemia, unspecified.
ICD-10 code: D47. 2 Monoclonal gammopathy of undetermined significance (MGUS)
ICD-10 | Monoclonal gammopathy (D47. 2)
A benign condition in which there is a higher-than-normal level of a protein called m protein in the blood. Patients with mgus are at an increased risk of developing cancer. A laboratory test result indicating the presence of an abnormally high level of monoclonal immunoglobulins in the blood or urine.
Causes. Causes of paraproteinemia include the following: Leukemias and lymphomas of various types, but usually B-cell non-Hodgkin lymphomas with a plasma cell component. Idiopathic (no discernible cause): some of these will be revealed as leukemias or lymphomas over the years.
Monoclonal gammopathies are conditions in which abnormal proteins are found in the blood. These proteins grow from a small number of plasma cells in the bone marrow. Plasma cells are a type of white blood cell. Their main job is to fight off infection.
Monoclonal gammopathy of undetermined significance (MGUS) is a condition in which an abnormal protein — known as monoclonal protein or M protein — is in your blood. This abnormal protein is formed within your bone marrow, the soft, blood-producing tissue that fills in the center of most of your bones.
There are 3 subtypes of MGUS, namely, immunoglobulin M (IgM) MGUS, non-IgM MGUS, and light-chain MGUS, each with distinct rate and type of progression (Table 1).
A monoclonal gammopathy is when plasma cells make too many copies of the same antibody. It is usually found on a routine blood test when looking for other conditions. Although people with multiple myeloma have a monoclonal gammopathy, not everyone with monoclonal gammopathy has multiple myeloma.
ICD-10 code: C90. 00 Multiple myeloma Without mention of complete remission.
Paraproteinemia, also known as monoclonal gammopathy, is characterized by the presence of excessive amounts of paraproteins in the blood. Paraproteins are immunoglobulin proteins that are produced by a clone of plasma cells in the bone marrow. These proteins often cause damage to the kidneys.
M proteins go by a lot of different names. You may hear your doctor call them "monoclonal " proteins. They're also called monoclonal immunoglobulin, mylenoma, M spike, or paraprotein. Whatever their name, they're made in your bone marrow, the spongy tissue in the middle of many bones.
Immunoglobulin M (IgM) paraproteinaemias comprise 15–20% of monoclonal proteins but pose unique clinical challenges. IgM paraproteins are more commonly associated with lymphoplasmacytic lymphoma than multiple myeloma and can occur in a variety of other mature B-cell neoplasms.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A laboratory test result indicating the presence of an abnormally high level of monoclonal immunoglobulins in the blood or urine.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
The 2022 edition of ICD-10-CM D47.2 became effective on October 1, 2021.
Hypogammaglobulinemia co-occurrent and due to monoclonal gammopathy of undetermined significance
The 2022 edition of ICD-10-CM D89.2 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Abnormality of plasma protein, unspecified 1 R77.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM R77.9 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of R77.9 - other international versions of ICD-10 R77.9 may differ.
The 2022 edition of ICD-10-CM R77.9 became effective on October 1, 2021.
273.1 is a legacy non-billable code used to specify a medical diagnosis of monoclonal paraproteinemia. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Patients with IgM MGUS lack the signs and symptoms of an overt lymphoproliferative disorder of plasma cell neoplasm, and the paraprotein is typically discovered incidentally on serum protein electrophoresis.
IgM monoclonal gammopathy of undetermined significance (MGUS) is defined by a serum IgM paraprotein concentration < 30 gram per liter; bone marrow lymph oplasmacytic infiltration of < 10%; and no evidence of anemia, constitutional symptom s, hyperviscosity, lymphadenopathy, hepatosplenomegaly, or other end-organ damage that can be attributed to the underlying lymphoproliferative disorder..
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2020
The 2022 edition of ICD-10-CM R80.9 became effective on October 1, 2021.
Proteinuria. Proteinuria (protein in urine) Proteinuria due to type 2 diabetes mellitus (disorder) Clinical Information. A disorder characterized by laboratory test results that indicate the presence of excessive protein in the urine. It is predominantly albumin, but also globulin.